FindTrial
Sign In

Clinical study to evaluate the safety and efficacy of Pelvic floor biological stimulation feedback instrument

Clinical study to evaluate the safety and efficacy of Pelvic floor biological stimulation feedback instrument

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012209
Enrollment
Unknown
Registered
2017-08-01
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uracratia

Interventions

control group:treat according to protocol
experimental group :treat according to protocol

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Results of ICI-Q-SF is uracratia. Hand muscle strength below III level (excluding grade III); 18-75 years of age, female with childbearing history; Voluntary participation in the clinical trial and sign a informed consent.

Exclusion criteria

Exclusion criteria: History of cancer; History of epileptic; Pregnant woman; Wearing implantable electronic device; Vaginitis, urinary tract infection; Impaired perception and lack of coordination; Other situations the researchers do not agree.

Design outcomes

Primary

MeasureTime frame
ICI-Q-SF;Hand muscle strength;—

Countries

China

Contacts

Public ContactFu Qiang

Shanghai Sixth People's Hospital

jamesqfu@aliyun.com+86 13501834727

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026